Beautiful Plants For Your Interior
Intex Ment -50 Trestolone Acetate 50mg/ml
$70.00
Intex Ment-50 is an injectable anabolic-androgenic steroid containing Trestolone Acetate (also known as MENT or 7α-methyl-19-nortestosterone) at a concentration of 50 mg per mL, typically supplied in a 10 mL vial by Intex Pharma, a manufacturer associated with underground or performance-enhancing suppliers. It is an experimental synthetic derivative of nandrolone, originally developed for male contraception and hormone replacement but never marketed for human use.
Intex Ment -50
Intex Ment-50 is an injectable anabolic-androgenic steroid containing Trestolone Acetate (also known as MENT or 7α-methyl-19-nortestosterone) at a concentration of 50 mg per mL, typically supplied in a 10 mL vial by Intex Pharma, a manufacturer associated with underground or performance-enhancing suppliers. It is an experimental synthetic derivative of nandrolone, originally developed for male contraception and hormone replacement but never marketed for human use. Primarily abused off-label by bodybuilders and athletes for rapid muscle hypertrophy, strength gains, enhanced recovery, and fat loss due to its high anabolic potency (up to 10 times that of testosterone) and IGF-1 stimulation, though this is illegal without prescription and carries severe health risks.
How It Works
Trestolone Acetate is a potent 19-nor steroid that binds strongly to androgen receptors, promoting protein synthesis, nitrogen retention, and red blood cell production for significant lean mass and strength increases. Unlike non-aromatizing steroids, it converts to estrogen (aromatizes), leading to fuller gains but requiring management to avoid bloating. The acetate ester allows quick onset (effects in days) with a short half-life (about 8 hours), necessitating frequent dosing. It also boosts IGF-1 levels for superior muscle repair and growth, making it versatile for bulking or recomp cycles, though its progestogenic activity can mimic nandrolone-like effects.
Dosage and Administration
- Administered via deep intramuscular injection into large muscle groups (e.g., glutes or quads) using sterile technique; daily or every-other-day dosing due to short ester.
- Non-medical bodybuilding doses: 10-50 mg per day (0.2-1 mL total), often in 4-8 week cycles to minimize suppression—beginners start at 10-20 mg/day, advanced up to 50 mg. Weekly equivalent: 70-350 mg.
- For the 10 mL vial (500 mg total): Stack with testosterone base (e.g., 200-300 mg/week) for synergy; monitor bloodwork for hormones, lipids, and liver enzymes every 4 weeks. Post-cycle therapy (PCT) starts 3-5 days after last dose, using SERMs like clomiphene (50 mg/day weeks 1-2, 25 mg/day weeks 3-4) and tamoxifen (20 mg/day for 4 weeks) to restore natural testosterone.
Side Effects
Common side effects include:
- Estrogenic: Water retention, gynecomastia (breast tissue growth), mood swings, and fat gain (mitigate with aromatase inhibitors like anastrozole 0.5 mg EOD).
- Androgenic: Acne, accelerated hair loss (in genetically prone users), increased body hair, and aggression.
- Endocrine: Severe suppression of natural testosterone (leading to low libido, infertility, testicular atrophy), libido fluctuations.
Serious risks: Cardiovascular strain (elevated blood pressure, unfavorable cholesterol shifts—reduced HDL, increased LDL), liver stress (mild but monitor enzymes), potential progesterone-related issues (e.g., lactation-like symptoms), and injection-site pain or infection. Women face high virilization risk (irreversible voice deepening, clitoral enlargement). Long-term abuse may cause permanent hormonal imbalance or organ damage; discontinue immediately for severe symptoms like chest pain or jaundice and seek medical help.
Precautions and Warnings
- Contraindicated in prostate/breast cancer, severe heart/liver/kidney disease, pregnancy, breastfeeding, or allergies to components (e.g., carrier oil).
- Use extreme caution in those with high blood pressure, diabetes (may impair glucose control), or clotting disorders; not for minors (risks premature epiphyseal closure) or women. Suppresses HPTA axis aggressively—PCT mandatory.
Reviews
There are no reviews yet.